Review: taking Invega and Adderall 10 together


Summary

Drug interactions are reported among people who take Invega and Adderall 10 together. This review analyzes the effectiveness and drug interactions between Invega and Adderall 10. It is created by eHealthMe based on reports of 50 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Invega and Adderall 10 >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Invega

Invega has active ingredients of paliperidone. It is often used in schizophrenia. (latest outcomes from Invega 7,725 users)

Adderall 10

Adderall 10 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall 10 4,951 users)

On Jul, 24, 2016

50 people who take Invega, Adderall 10 are studied.


Number of reports submitted per year:

Invega and Adderall 10 drug interactions.

Drug effectiveness over time:

Invega:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Adderall 10:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (2 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Invega:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 1 people)
Adderall 10:
  • female: 100.0% - (3 of 3 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Invega:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Adderall 10:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (1 of 2 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • hypoaesthesia
  • paraesthesia oral
  • tongue disorder
  • adverse drug reaction
  • hallucination, auditory
  • hallucination, visual
  • psychotic disorder
1 - 6 months:
  • abnormal weight gain
6 - 12 months:
  • amenorrhoea
  • anger
  • blood prolactin increased
  • weight increased
1 - 2 years:
  • abnormal weight gain
  • adverse drug reaction
  • hallucination, auditory
  • hallucination, visual
  • psychotic disorder
not specified:
  • weight increased
  • abnormal behaviour
  • aggression
  • confusional state
  • dehydration
  • renal failure
  • somnolence
  • depression
  • hallucination, visual
  • chest discomfort

Most common drug interactions by gender *:

female:
  • confusional state
  • dehydration
  • renal failure
  • somnolence
  • hyporesponsive to stimuli
  • lethargy
  • mania
  • neuroleptic malignant syndrome
  • weight increased
  • bipolar disorder
male:
  • abnormal behaviour
  • weight increased
  • hallucination, visual
  • aggression
  • chest discomfort
  • essential hypertension
  • impulse-control disorder
  • mood swings
  • nasal congestion
  • schizophrenia, paranoid type

Most common drug interactions by age *:

2-9:
  • decreased appetite
  • homicidal ideation
  • suicidal ideation
  • underweight
10-19:
  • weight increased
  • abnormal behaviour
  • chest discomfort
  • essential hypertension
  • hallucination, visual
  • impulse-control disorder
  • nasal congestion
  • schizophrenia, paranoid type
  • type 1 diabetes mellitus
  • neuroleptic malignant syndrome
20-29:
  • aggression
  • depression
  • mood swings
  • abnormal behaviour
  • suicidal ideation
  • bipolar disorder
  • drug intolerance
  • homicidal ideation
  • impatience
  • pollakiuria
30-39:
  • alopecia
  • amnesia
  • dermatosis
  • galactorrhoea
  • hyperkeratosis
  • parakeratosis
  • pityriasis rosea
  • rash
40-49:
  • dehydration
  • renal failure
  • somnolence
  • confusional state
  • hyporesponsive to stimuli
  • lethargy
  • mania
  • accidental exposure
  • coordination abnormal
  • dysarthria

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Invega and Adderall 10?

Can you answer these questions?

More questions for: Invega, Adderall 10

You may be interested in these reviews

More reviews for: Invega, Adderall 10

On eHealthMe, Invega (paliperidone) is often used to treat schizophrenia. Adderall 10 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.